IRTC iRhythm Technologies Inc

$167.45

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/2/2025

About iRhythm Technologies Inc

iRhythm Technologies, Inc., a digital healthcare company, offers ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. The company is headquartered in San Francisco, California.

Website: https://www.irhythmtech.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1388658
Address
650 TOWNSEND STREET, SUITE 500, SAN FRANCISCO, CA, US
Valuation
Market Cap
$3.22B
P/E Ratio
nan
PEG Ratio
0.00
Price to Book
35.45
Performance
EPS
$-3.63
Dividend Yield
—
Profit Margin
-19.10%
ROE
-75.30%
Technicals
50D MA
$105.89
200D MA
$88.51
52W High
$128.52
52W Low
$55.92
Fundamentals
Shares Outstanding
32M
Target Price
$130.92
Beta
1.45

IRTC EPS Estimates vs Actual

● Estimated
● Actual

IRTC News & Sentiment

Sep 18, 2025 • Benzinga NEUTRAL
IRHYTHM INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of iRhythm Technologies, Inc. - IRTC - iRhythm Technologies ( NASDAQ:IRTC )
NEW YORK and NEW ORLEANS, Sept. 18, 2025 ( GLOBE NEWSWIRE ) -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ( "KSF" ) , announces that KSF continues its investigation into iRhythm Technologies, Inc. IRTC.
Sep 02, 2025 • Zacks Commentary SOMEWHAT-BULLISH
IRTC Unveils Positive AMALFI Trial Data Showing Higher AF Detection
iRhythm's AMALFI trial shows its Zio monitoring service boosts AF detection and speeds diagnosis, strengthening its edge in cardiac care.
Aug 29, 2025 • GlobeNewswire SOMEWHAT-BULLISH
AMALFI Randomized Clinical Trial Results Demonstrate Increased Atrial Fibrillation Diagnosis with Home-Based Long-Term Continuous ECG Monitoring Using iRhythm Technologies' Zio LTCM Service
SAN FRANCISCO, Aug. 29, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) announced results from the Oxford University-led Active Monitoring for AtriaL FIbrillation ( AMALFI ) randomized clinical trial, presented at the European Society of Cardiology ( ESC ) Congress 2025 and ...
Aug 20, 2025 • Benzinga BULLISH
iRhythm Technologies to Participate in Upcoming Investor Conferences - iRhythm Technologies ( NASDAQ:IRTC )
SAN FRANCISCO, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. IRTC, a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following investor ...
Aug 20, 2025 • GlobeNewswire BULLISH
iRhythm Technologies to Participate in Upcoming Investor Conferences
SAN FRANCISCO, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- iRhythm Technologies, Inc. ( NASDAQ:IRTC ) , a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that its management team is scheduled to present at the following ...
Aug 20, 2025 • Benzinga SOMEWHAT-BULLISH
This Figma Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday - Applied Mat ( NASDAQ:AMAT ) , Establishment Labs Hldgs ( NASDAQ:ESTA )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Sentiment Snapshot

Average Sentiment Score:

0.309
50 articles with scored sentiment

Overall Sentiment:

Bullish

IRTC Reported Earnings

Apr 30, 2025
Mar 31, 2025 (Pre market)
-0.26 Surprise
  • Reported EPS: $-0.95
  • Estimate: $-0.69
  • Whisper: —
  • Surprise %: -38.0%
Feb 20, 2025
Dec 31, 2024 (Post market)
0.29 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.28
  • Whisper: —
  • Surprise %: 103.6%
Oct 30, 2024
Sep 30, 2024 (Post market)
-0.69 Surprise
  • Reported EPS: $-1.26
  • Estimate: $-0.57
  • Whisper: —
  • Surprise %: -121.0%
Aug 01, 2024
Jun 30, 2024 (Post market)
0.28 Surprise
  • Reported EPS: $-0.61
  • Estimate: $-0.89
  • Whisper: —
  • Surprise %: 31.5%
May 02, 2024
Mar 31, 2024 (Post market)
-0.27 Surprise
  • Reported EPS: $-1.23
  • Estimate: $-0.96
  • Whisper: —
  • Surprise %: -28.1%
Feb 22, 2024
Dec 31, 2023 (Post market)
-0.66 Surprise
  • Reported EPS: $-1.26
  • Estimate: $-0.60
  • Whisper: —
  • Surprise %: -110.0%
Nov 02, 2023
Sep 30, 2023 (Post market)
-0.23 Surprise
  • Reported EPS: $-0.89
  • Estimate: $-0.66
  • Whisper: —
  • Surprise %: -34.9%
Aug 03, 2023
Jun 30, 2023 (Post market)
0.17 Surprise
  • Reported EPS: $-0.61
  • Estimate: $-0.78
  • Whisper: —
  • Surprise %: 21.8%
May 04, 2023
Mar 31, 2023 (Post market)
-0.2 Surprise
  • Reported EPS: $-1.10
  • Estimate: $-0.90
  • Whisper: —
  • Surprise %: -22.2%

Financials